About AB City

"AB City" is the parent company of two commercially and socially significant joint stock companies: AS "Repharm" and AS "Olpha". The conglomerate includes healthcare, pharmaceutical retail and wholesale, production companies and laboratory test service providers operating in the Baltic region with a total annual turnover of over EUR 500 million.

People and health are the focus for the businesses and brands represented by "AB City", producing medicines at "Olpha", providing services at "Mēness aptieka pharmacies", "Veselības centru apvienība" medical institutions, branches of "Centrālā laboratorija", the wholesaler "Recipe Plus" as well as plant-based medicines at "Rīgas Farmaceitiskā fabrika".

Read more

We believe that affordable health care means healthier society and happier people.

Latest news

A safe and supportive environment for patients: the importance of collaboration between psychiatrists and pharmacists

A safe and supportive environment for patients: the importance of collaboration between psychiatrists and pharmacists

28 February 2025

To improve knowledge and understanding of the care of people with mental and behavioural disorders, pharmacists from “Mēness aptieka” visited the National Centre for Mental Health on 27 February.

Read more
Mental health balance is fragile. It’s important to recognise the problem.

Mental health balance is fragile. It’s important to recognise the problem.

25 February 2025

During the expert discussion “Mental Health Balance. Boundaries. How to recognise, understand and help?”, organised by “Mēness aptieka”, which focused on early recognition of mental disorders and ways to get timely help, experts stressed the importance of being honest with oneself and not pretending the problem doesn`t exist.

Read more
“Olpha” submits 38 new medicines for EU registration; three new medicines already available to patients in the Baltics

“Olpha” submits 38 new medicines for EU registration; three new medicines already available to patients in the Baltics

20 February 2025

The Latvian pharmaceutical company Olpha continues to work intensively on developing its product portfolio and expanding its exports in the European Union (EU).

Read more